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Abstract
Background: Current guidance regarding the role of daily breakfast in human health is largely grounded in cross-
sectional observations. However, the causal nature of these relationships has not been fully explored and what
limited information is emerging from controlled laboratory-based experiments appears inconsistent with much
existing data. Further progress in our understanding therefore requires a direct examination of how daily breakfast
impacts human health under free-living conditions.
Methods/Design: The Bath Breakfast Project (BBP) is a randomised controlled trial comparing the effects of daily
breakfast consumption relative to extended fasting on energy balance and human health. Approximately 70 men
and women will undergo extensive laboratory-based assessments of their acute metabolic responses under fasted
and post-prandial conditions, to include: resting metabolic rate, substrate oxidation, dietary-induced thermogenesis
and systemic concentrations of key metabolites/hormones. Physiological and psychological indices of appetite will
also be monitored both over the first few hours of the day (i.e. whether fed or fasted) and also following a
standardised test lunch used to assess voluntary energy intake under controlled conditions. Baseline measurements
of participants’ anthropometric characteristics (e.g. DEXA) will be recorded prior to intervention, along with an oral
glucose tolerance test and acquisition of adipose tissue samples to determine expression of key genes and
estimates of tissue-specific insulin action. Participants will then be randomly assigned either to a group prescribed
an energy intake of ≥3000 kJ before 1100 each day or a group to extend their overnight fast by abstaining from
ingestion of energy-providing nutrients until 1200 each day, with all laboratory-based measurements followed-up 6
weeks later. Free-living assessments of energy intake (via direct weighed food diaries) and energy expenditure (via
combined heart-rate/accelerometry) will be made during the first and last week of intervention, with continuous
glucose monitors worn both to document chronic glycaemic responses to the intervention and to verify
compliance.
Trial registration: Current Controlled Trials ISRCTN31521726.
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It is over four decades since Pavel Fábry and colleagues
published their studies showing positive correlations
between infrequent daily meal patterns and overweight,
hypercholesterolaemia, impaired glucose tolerance and
ischaemic heart disease [1]. Since then, it is certainly
n o t a b l et h a tt h ei n c r e a s e dp r e v a l e n c eo fo v e r w e i g h ta n d
obesity in Western Societies has been paralleled by a pro-
gressive decline in breakfast consumption [2]. However,
subsequent scientific literature has not substantially pro-
gressed understanding beyond the initial cross-sectional
associations published in the late 1960s. While subse-
quent cross-sectional and/or longitudinal investigations
have undoubtedly clarified certain aspects of these corre-
lations and confirmed such relationships across a wider
population range, it is impossible to establish any degree
of causality from these data due to major confounding
variables; for example, the fact that frequent breakfast
consumers also tend to exhibit numerous other healthful
lifestyle choices such as lower fat/alcohol intakes, higher
fibre/micronutrient intakes, not smoking and also a ten-
dency to exercise more [3-11].
In terms of existing cross-sectional evidence linking
increased adiposity with infrequent or insufficient break-
fast consumption, the wealth of available literature does
conform to the stated positive relationship [1,7,11-21]].
However, the majority of these large-scale epidemiologi-
cal studies have involved self-reported dietary records,
which are known to underestimate absolute energy
intake to a greater extent for more overweight individuals
[22]. Indeed, Summerbell et al. (1995) reanalysed the data
from 3 existing studies across a range of age groups and
found that the commonly reported associations between
frequent daily meal patterns/high energy intake at break-
fast and overweight do not persist once corrected for
‘unreasonably low’ energy intakes [23]. These corrected
results therefore fall into agreement with the one other
existing cross-sectional study which found no relation-
ship between daily meal frequency and percent body fat-
ness as determined by hydrostatic weighing, in which
dietary records were managed on an individual basis via
telephone [24]. Notwithstanding such methodological
issues, it might be suggested that one benefit of a fre-
quent meal pattern would be a lasting satiating effect,
possibly related to the high fibre content of many break-
fast foods [25]. Indeed, at least three intervention studies
are consistent with this reasoning [26-28], although many
cross-sectional studies have not observed any difference
in overall energy intake between frequent and infrequent
breakfast consumers [12,13,17,29] or have even found
higher energy intakes associated with breakfast consump-
tion [13,15,16,20]. These latter studies necessarily impli-
cate some interaction between energy intake and energy
expenditure (i.e. if breakfast consumers are leaner),
although the only evidence for such an effect comes from
the study by Wyatt et al. (2002), in which self-reported
physical activity was higher amongst individuals who
reported having breakfast on more than 3 days each
week [29]. Ultimately, the balance of currently available
cross-sectional evidence cannot provide information
regarding the direction or even the existence of any cau-
sal relationship between breakfast consumption and
weight change. Moreover, issues regarding the accurate
measurement of changes in energy intake may even ques-
tion the validity of these findings.
To gain greater insight into this field, it is necessary to
move towards higher levels of evidence beyond simple
cross-sectional observations. Fortunately, five of the stu-
dies that have documented baseline correlations between
weight status and breakfast frequency have also con-
ducted longitudinal examinations of breakfast habits and
weight change over between 3 and 13 years in both chil-
dren [11,18,20] and adults [19,21]. In contrast to the
cross-sectional evidence detailed above, a far less consis-
tent pattern of findings is apparent. Barton et al. (2005),
Timlin et al. (2008) and Bazzano et al. (2005) have all
reported a reduced prospective risk of weight gain with
frequent breakfast consumption over 5-10 years follow-
up in children [18], adolescents [11] and adults [19],
respectively; while Kant and colleagues found no rela-
tionship whatsoever between weight change over 8-10
years and daily meal pattern either at baseline or at fol-
low-up, although an infrequent daily meal pattern does
not necessarily indicate that breakfast was omitted [21].
Interestingly, in that study the authors also note that
daily meal pattern was unrelated to self-reported physical
activity either at baseline or at follow-up, although no
actual data are reported. The balance of longitudinal evi-
dence in this area becomes yet more equivocal when con-
sidering the study by Berkey et al. (2003), in which a
large cohort of children between the ages of 9 and 14
were monitored annually over three years [20]. Impor-
tantly, this study also stratified participants according to
weight and actually found omission of breakfast to be
positively associated with prospective weight loss in over-
weight children. In contrast, normal weight children in
this study displayed a trend in the opposite direction in
that more weight was gained over time when breakfast
was always omitted rather than consumed. It is also note-
worthy that recent longitudinal evidence has reported
detrimental cardiovascular and metabolic health out-
comes in association with breakfast skipping even when
adjusted for physical activity status and increased body
fatness [i.e. waist circumference; [30]]. Overall, the longi-
tudinal studies summarised here question the causal nat-
ure of cross-sectional associations between breakfast and
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that the strength and direction of this relationship may
be mediated by current weight status.
Evidence from randomised controlled trials in this
area comes from a wide range of innovative research
designs with varied research questions. Specifically,
many of these studies have focused on either consuming
a low energy breakfast or reducing the number of meals
consumed on a daily basis, as opposed to the complete
omission of breakfast per se [27,31,31-44]. In terms of
the former, low energy breakfasts have been found to
increase subsequent energy intake during a test meal 4
hours later [34] but not sufficiently to compensate for
the reduced energy intake at breakfast [36,45]. In fact,
even if overall energy intake is unaffected, it seems that
reducing energy intake at breakfast for 6 weeks may
actually result in greater reductions in body fat mass but
lower overall weight loss due to the preservation of lean
tissue mass [35]. Conversely, those studies which have
varied the number of meals consumed on a daily basis
from between 1 and 9 meals per day have found no
effect on energy intake, resting energy expenditure or
change in body mass [27,31-33,46-48], although one
recent study has reported an increase in fat mass with
omission of an afternoon meal for 28 days [47] and
another has detected higher overall energy intake from
meals of prescribed content during a 14 day period of
breakfast omission [26]. The effects of varied meal fre-
quency on dietary-induced thermogenesis (DIT) are
even less consistent, with reports of DIT being either
unaffected [27,40,41], increased [37,38] or in fact
decreased [32,39] by an infrequent daily feeding pattern.
In terms of selected health outcomes typically associated
with chronic weight change, causal evidence is also
inconsistent with what might be expected based upon
cross-sectional observations. For example, there is some
tentative evidence that a regular daily meal frequency
(6-9 meals per day) for 2 weeks can improve insulin
sensitivity and blood lipid profiles relative to more chao-
tic and/or less frequent feeding patterns [43,44]. It is
therefore intriguing that intermittent 24 hour fasting
every other day for 2 weeks also has the capacity to
improve insulin sensitivity, even without any significant
short-term reduction in body mass [49]. However, such
alternate-day fasting also reduces resting metabolic rate,
so may favour weight gain and associated consequences
in the long-term [50].
Nonetheless, as mentioned previously, neither varied
meal frequency nor reduced energy intake at breakfast
necessarily precludes the ingestion of food in the morn-
ing to interrupt an overnight fast. It is therefore very
interesting that so few randomised controlled trials have
directly contrasted the impact of omitting breakfast (i.e.
extending the daily overnight fast) from an otherwise
matched diet in terms of components of energy balance
and subsequent weight loss [26,46,51]. One of these stu-
dies has already been discussed in relation to the
observed increase in energy intake when breakfast was
omitted from the habitual diet [26] but also reported
evidence of impaired glycaemic control and elevated
blood lipids with breakfast omission, despite the fact
that body mass was unaffected. These findings are con-
sistent with the more recent work of Stote et al.( 2 0 0 7 )
in relation to changes in body mass over 8 weeks of
extended morning fasting [46], along with metabolic
data taken from the same study [52]. The third trial spe-
cific to inclusion/omission of breakfast from the habitual
diet also involved prescribed dietary intake but with
restricted energy intake (i.e. ~ 5000 kJ·d
-1) over a period
of 12 weeks, provided either as 3 meals each day
(including a cereal breakfast) or with 2 meals each day
(including an additional bran muffin with each meal to
maintain energy/fibre intake) [51].
Importantly, the authors of this latter study also strati-
fied participants according to their usual breakfast eating
habits at baseline and found habitual breakfast consu-
mers lost more weight by omitting breakfast while habi-
tual breakfast non-consumers lost more weight by
introducing breakfast. This study therefore indicates that
the success of a weight loss programme can be mediated
to an extent by the degree to which that programme dif-
fers from each individual’s usual dietary habits but also
revealed that not consuming breakfast increases the
probability of impulsive snacking throughout the day,
which is known to be associated with a poorer overall
dietary profile [53]. It should be noted, however, that all
t h r e eo ft h es t u d i e sc i t e da b o v eh a v ei n v o l v e ds o m e
degree of prescription or restriction in terms of dietary
intake, so may not therefore be sensitive to potential
‘real-world’ alterations in eating behaviour and, further-
more, only the study by Stote et al. (2007) has attempted
to quantify any effect of interventions on free-living
energy expenditure. In that study, accelerometers (Acti-
graph™) were used to monitor weekly physical activity
counts and it was reported that there was no evidence of
any difference in physical activity between treatments
[46]. However, this measurement tool has been shown to
lack reliability when applied to free-living conditions [54]
and may not therefore have been sufficiently sensitive to
detect subtle alterations in spontaneous low-to-moderate
intensity physical activity [55], which intuitively could be
considered as the most responsive element of physical
activity to modified eating patterns.
What becomes most clear when reviewing the above lit-
erature is that very few existing studies have actually
attempted to quantify the impact of breakfast on the most
malleable component of energy expenditure, namely phy-
sical activity energy expenditure [27,29,31,38,42,46]. Even
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reported cross-sectional associations based upon a self-
administered physical activity questionnaire [29], while
four others were randomised controlled trials that directly
assessed energy expenditure using a whole-body calori-
meter [although this method understandably restricts par-
ticipants’ spontaneous free-living physical activity;
[27,31,38,42]]. Therefore, aside from the aforementioned
study by Stote et al. in which overall physical activity level
was estimated using accelerometers [46], only Verboeket-
van de Venne et al. (1993) have provided data regarding
changes in daily physical activities with varied feeding fre-
quency (i.e. 2 versus 7 meals·d
-1). Physical activity levels in
that study were determined as the difference between rest-
ing energy expenditure measured using the whole-body
calorimeter and average daily free-living energy expendi-
ture measured using the doubly-labelled water technique,
which revealed no effect of feeding frequency [38].
A central aim of this project is therefore to conduct a
trial in accordance with current CONSORT guidelines
which will employ contemporary measurement tools (i.e.
combined heart rate and accelerometry) to generate objec-
tive and reliable data regarding physical activity energy
expenditure under free-living conditions in response to
varied daily meal frequency (i.e. daily breakfast versus
extended fasting). In contrast to doubly-labelled water,
this approach is not limited only to monitoring total
energy expenditure but also permits specific evaluation of
physical activity profiles in terms of the precise intensity
and duration of various daily activities. This novel aspect
of the work is complemented by both laboratory- and
field-based assessments of all other components of energy
balance, along with integration of various other techniques
not previously combined in relation to this dietary inter-
vention. In particular, changes in body composition will be
accurately monitored via repeated DEXA scanning, con-
tinuous glucose monitors will provide a highly sensitive
and meaningful analysis of glycaemic control with modi-
fied feeding patterns and, lastly, detailed blood/adipose tis-
sue analyses will provide the most mechanistic
information to date on this topic, thus establishing the
existence and direction of any causal relationships between
variables. In summary, there is some support for a positive
relationship between extended daily fasting and energy
balance, which can lead to a range of inter-related negative
health consequences, and this project aims to address the
casual nature of these associations via the following
objectives:
i.) To examine the impact of a single extended fast
on the acute metabolic and behavioural mechanisms
of short-term energy balance regulation.
ii.) To determine whether habitual extended fasting
is causally related to chronic positive energy balance
and establish the mechanisms through which this
relationship may operate.
iii.) To translate the effects of habitual extended
fasting into selected health outcomes related to
chronic positive energy balance (i.e. adiposity, insulin
resistance and cardiovascular disease).
Methods/Design
Approach to the Research Question
As illustrated in Figure 1, extended daily fasting has the
potential to impact upon adiposity, insulin resistance and
cardiovascular disease via the acute influences of a single
extended daily fast on a given day in terms of contribut-
ing to a more positive daily energy balance (Objective i)
but also via the chronic metabolic and/or behavioural
adaptations which may occur with habitual exposure to
extended daily fasting over a more prolonged period
(Objective ii). This project will take advantage of recent
technological advances to comprehensively assess all
aspects of energy balance and the physiological mechan-
isms which may underpin causal relationships between
feeding frequency and energy balance (i.e. energy balance
hormones). Furthermore, this approach of applying state-
of-the-art analytical techniques to further progress cur-
rent understanding will also provide valuable insight by
examining selected health-related outcomes at a variety
of levels ranging from molecular to whole-body (Objec-
tive iii). Specifically, many components and conse-
quences of positive energy balance (e.g. poor dietary
composition, sedentary behaviour and adiposity) have
been well established as independent risk factors for
insulin resistance and associated cardiovascular disease
[56-58], with chronic low-grade inflammation strongly
implicated in the latter [59]. In particular, systemic con-
centrations of C-reactive protein (CRP) have been shown
to exhibit positive correlations with fasted glucose con-
centrations [60], atherosclerotic progression [61] and the
incidence of initial coronary heart disease events [62]. It
is therefore anticipated that the range of measures
described below will address the stated objectives both
from a basic and an applied science perspective to estab-
lish causal mechanisms and relationships to clinical out-
comes, thus providing detailed yet practically valuable
understanding in relation to public health policy and
clinical practice.
Trial Design
Objective i will be addressed by way of an acute rando-
mised cross-over comparison while Objective ii and
Objective iii will be addressed via a chronic independent
comparison of two parallel and randomly assigned
groups, both involving a contrast between daily breakfast
consumption and extended fasting. Figure 2 illustrates
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current CONSORT guidelines for reporting randomised
trials [63].
Participants/Eligibility
A total cohort of 60-70 men and women will take part
in the main part of the experiment, half of whom will
be broadly classified as normal weight (BMI ~20-25
kg·m
-2), whereas the other half will be obese (BMI ≥30
kg·m
-2). This broad classification according to BMI is
intended to generate two separate and diverse overall
populations for subsequent more accurate and gender
specific stratification based upon DEXA-derived fat-
mass index (♂ FMI ≤7.5 kg·m
-2<; ♀ FMI ≤11 kg·m
-2<),
Figure 1 Proposed mechanistic pathway underlying the relationships between extended daily fasting, energy balance and health
outcomes.
Figure 2 Flow diagram illustrating progress through each phase of the trial [adapted from current CONSORT guidelines; [63]].
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allow separate analyses according to whether a given
individual is ordinarily able to attain long-term energy
balance. Furthermore, baseline breakfast habits will be
included as a co-variate in our analysis to consider the
distinct responses of frequent versus infrequent breakfast
consumers, with frequent breakfast consumption defined
as the ingestion of ≥209 kJ within two hours of waking
on most days of the week. Both the above factors will
be included in a stratified randomisation scheme, with
generation of 4 separate block randomisation schedules
to ensure an equal distribution of normal/overweight
and in/frequent breakfast consumers between treatment
groups. These randomisation schedules will be produced
by the principal investigator (JB) using a computer-
based random number generator, with full details of the
overall randomisation scheme only to be published in
full once group allocation is complete to complicate
deciphering of the allocation sequence by those involved
in trial enrolment [65]. Further procedures to conceal
the allocation sequence are that the two individuals
responsible for trial enrolment (JR & EC) will indepen-
dently request group assignments from the principal
investigator via email immediately upon verification of
eligibility according to pre-stated inclusion criteria.
Combining these separate requests into the same set of
randomisation schedules in order of receipt therefore
renders it impossible for either individual to confidently
predict upcoming group assignments without prior
knowledge of the other’s requests. Moreover, even with
this knowledge, randomisation at the point of objectively
establishing eligibility ensures that the sequence in
which requests are received is determined before ade-
quate information becomes available to predict the likely
responsiveness of any given individual to each
treatment.
Lastly, any volunteer fulfilling all eligibility criteria
(thus equivalent to the main study population) but
unable to commit to the main study for other reasons
(e.g. impossible to schedule trials in the required time-
frame, unwilling to provide tissue samples, etc.) will be
invited to participate as part of a ‘true’ control group.
This group will complete only the free-living element of
the study (Phase II; see later) while simply maintaining
their usual lifestyle, therefore providing some back-
ground context regarding the extent to which the free-
living measures themselves (i.e. dietary & physical activ-
ity monitoring) may impact outcomes but without
necessitating any extended visits to the laboratory for
tissue samples. These volunteers for the proposed work
will be recruited from the local community (South West
UK) via public advertisement (e.g. local press/radio) and
will not be provided any financial incentive for partici-
pation. The protocol described herein was reviewed and
approved by the National Health Service South West 3
Research Ethics Committee (10/H0106/13).
Inclusion Criteria
￿ Aged 21-60
￿ Body Mass Index 20-25 kg·m
-2 or >30 kg·m
-2
￿ Able and willing to safely comply with all study
procedures
￿ Able to provide written informed consent for
participation
￿ Females must maintain a record of regular men-
strual cycle phase or contraceptive use
￿ No anticipated changes in diet and/or physical
activity habits during the study period (e.g. pre-
planned holidays, diets/exercise plan, etc.)
Exclusion Criteria
￿ Any reported condition or behaviour deemed
either to pose undue personal risk to the participant
or introduce bias into the experiment
￿ Any reported use of substances which may pose
undue personal risk to the participants or introduce
bias into the experiment
￿ Any individual whose habitual lifestyle does not
conform to a standard sleep-wake cycle (e.g. shift
workers)
￿ Simultaneous or recent (i.e. last 3 months) partici-
pation in another clinical trial or blood donation, to
allow full recovery of blood volume [66]
￿ Any reported recent (i.e. last 6 months) shift (>1
kg) in body mass
￿ Any reported tendency towards keloid scarring
￿ Any reported bleeding disorder
￿ Females known to be pregnant or planning to
become so over the course of the study
￿ Females with oral or implanted contraceptives
fitted within 6 months of participation [67]
￿ Females who are breastfeeding
Statistical Approach/Power Estimation
The number of research participants to be recruited was
estimated based upon a worthwhile effect dictated by
the smallest shift in energy balance necessary to induce
chronic weight loss. Specifically, one of the most similar
studies to the proposed work applied doubly-labelled
water to measure average daily energy expenditure in a
population not dissimilar to that planned [38], from
which a mean of ~12000 kJ·d
-1 m i g h tb ee x p e c t e dw i t h
a standard deviation in the region of ~2000 kJ·d
-1.T h e
daily breakfast to be consumed in this trial will provide
in excess of ~3000 kJ·d
-1 a n do u rp i l o tw o r ku s i n gt h i s
breakfast indicates that this is likely to stimulate meta-
bolism in the lead up to lunch by ~150 kJ·d
-1 and
reduce energy intake at lunch by ~150 kJ·d
-1, relative to
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to exert a worthwhile effect on net energy balance (i.e.
sufficient to compensate for the energy it provides
directly), physical activity energy expenditure would
need to increase and/or subsequent energy intake to
decrease by a further 2700 kJ·d
-1.U s i n gt h ea b o v ef i g -
ures, a worthwhile increase in energy expenditure would
require ~14 participants in each treatment group to
confer a 90% probability of detecting such an effect sta-
tistically using a two-tailed t-test with an alpha level of
0.05. A total of 70 participants will therefore be
recruited for the main study treatment arms in view of
the 14% drop-out rate reported by Schlundt et al.
(1992) when placing similar demands on volunteers
[51], thus aiming to achieve at least 60 participants to
provide sufficient statistical power even when the overall
breakfast versus no breakfast groups are stratified
according to FMI (with baseline breakfast habits, gender
and age included as co-variates in the analysis). None-
theless, to minimise the negative impact of loss to fol-
low-up on validity, participants will be advised at trial
enrolment to very carefully consider the required invest-
ment of time and effort relative to their current and
forthcoming commitments outside of the trial, such that
exclusions based on likely withdrawal can be made prior
to randomisation [68]. Any unforeseen circumstances or
withdrawal of consent subsequently resulting in loss to
follow-up will be documented fully in the final trial
report. Data collected from these individuals to the
point of loss will then be compared with those who
complete each treatment to determine whether the over-
all conclusions of the trial may be generalised beyond
populations reflective of the latter (i.e. to anyone willing
to be randomised).
As with the primary outcome measure, secondary
variables will also be analysed using either paired or
independent t-tests applied to simple summary statistics
between groups or trials, respectively (e.g. fasted/peak
values, incremental area under curve, average value over
24 h, etc.). Given that these sample size estimations are
based on a primary outcome that inherently displays a
relatively large inter-individual variability, it is antici-
pated that the more consistent responses of secondary
variables will also be detectable with the selected sample
size.
Experimental Protocol
Objective i - T h ef i r s tp h a s eo ft h ep r o p o s e dw o r k
(Phase I) will involve two laboratory-based examinations
of the acute metabolic and behavioural responses to
extended fasting relative to ingestion of a standardised
breakfast. These trials will be applied in a randomised
and counterbalanced order with 3-28 days interval
except for eumenorrheic women, whose trials will be
separated by 28 ± 2 days and only at least 3 and at most
10 days after the onset of menses (i.e. follicular phase)
to ensure that the effects of menstrual cycle on the
majority of hormones and therefore resting metabolic
rate (RMR) and appetite will be both minimal and stan-
dardised between trials [69-71]. These acute trials will
be conducted in our resting metabolism laboratory in
accordance with current guidelines for best practice in
measuring resting metabolic rate [72]. Most notably,
ambient temperature in this laboratory is maintained
between 20 and 25°C (with intra-individual trials stan-
dardised within 2°C) and participants will arrive for test-
i n ga t8a m( ± 1h )i na1 0h o u rf a s t e ds t a t eb u th a v i n g
ingested 1 pint of plain water upon waking following
standardised physical activity and diet (the latter to
incorporate either daily breakfast or extended fasting
according to the group randomisation described later,
thus permitting meaningful comparisons with follow-up
visits). Repeated 5 minute resting expired gas samples
will be collected over 30 minutes (after 20 minutes of
quiet rest) to establish RMR and substrate selection
before a cannula will be fitted to an antecubital vein for
the acquisition of a baseline 15 ml blood sample, along
with further samples throughout that day.
At this stage, participants will provide ratings of hun-
ger and appetite using validated visual analogue scales
[73], for subsequent follow-up post-breakfast and also
pre-post lunch and at the end of day. They will then
receive either no breakfast or a typical standardised
breakfast (composed of cereal, toast and orange juice)
with the opposite treatment applied in each participant’s
second trial). The specific food and macronutrient com-
position of this breakfast has been described previously
[74] and provides quantities intended to deliver 14 mg
carbohydrate per kJ of each individual’sp r e v i o u s l y
established RMR. Fifteen minutes later or upon comple-
tion of the breakfast (if longer than 15 minutes is
required) a 3 hour post-prandial period will commence,
involving collection of all urine output (for determina-
tion of urea nitrogen excretion) with hourly expired 5
minute gas samples to assess changes in substrate meta-
bolism (i.e. carbohydrate, lipid and protein oxidation)
and DIT (i.e. post-prandial energy expenditure minus
RMR). Fifteen millilitre blood samples (including 5 ml
waste) will also be drawn 15, 30 & 60 minutes post-
breakfast, then at hourly intervals to determine systemic
concentrations of: glucose; lactate; insulin; NEFA; urea;
‘energy balance hormones’ that are known to play a cen-
tral role in the regulation of metabolic rate, appetite and
spontaneous physical activity (e.g. free thyroxine, adipo-
nectin, CCK, total/acylated ghrelin, leptin & PYY); and
also cytokine concentrations (e.g. interleukin-6 and
TNF-a), in view of recently documented differences in
post-prandial inflammatory responses to varied meals
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lipoprotein cholesterol and CRP only followed-up at the
3 hour time-point). Participants will then be provided
with a test meal of standardised composition (1 kg
cooked Sainsbury’s™ penne pasta and Ragu™ tradi-
tional tomato sauce; prepared at a ratio of 1:1 uncooked
mass) along with ad libitum plain water (although parti-
cipants will ingest the same volume of water as in their
first trial during all subsequent visits), which we have
previously employed during pilot work to estimate likely
differences in voluntary energy intake. At this stage, par-
ticipants will be left alone in the laboratory and receive
a recorded message stating: “We ask that you continue
eating until you have satisfied your hunger. The lunch
will remain in front of your for at least 30 minutes, at
which point the post-lunch timer will be started,
although you will be allowed to continue eating if you
are still hungry.”
The bowl of pasta will be refilled every 10 minutes to
minimise any visual feedback in the regulation of appe-
tite. To gain additional insight regarding psychological
reward and food hedonics, a validated labelled magni-
tude scale [76] will be administered following the first
and last mouthful of this meal to reliably assess the
degree of ‘pleasantness’ associated with ingestive beha-
viour. The 3 hour post-prandial period will then be
repeated exactly as following breakfast (but without the
15-30 minute samples) to track metabolic responses to
lunch.
Objective ii - Phase II of testing will commence
within 3-28 days after completion of each participants’
second trial under Phase I of testing (thus using partici-
pants’ breakfast trial along with the measures described
above as a baseline). This trial schedule will again be
used for all participants other than for eumenorrheic
women, who will follow the same restrictions as
described above and therefore occasionally be required
to complete their first trial under Phase II prior to the
completing the second trial under Phase I. In such
cases, these participants’ 6-week intervention will simply
be deferred for two weeks (i.e. enabling completion of
Phase I) to allow follow-up measures to be taken at the
same stage in the menstrual cycle. The first visit under
Phase II will begin with participants again arriving in
the laboratory at 8 am (±1 h) having adhered to the
same standardisation procedures as described for Phase
I. Measurements of body mass and adiposity based on
hip and waist circumference (i.e. widest gluteal girth &
mid-point between lowest rib and iliac crest, respec-
tively), sagittal abdominal height (using a Holtain-Kahn
calliper at the iliac crest) and body composition via
DEXA (Hologic Discovery W) will also be made at this
visit, before a small (~1 g) sample of subcutaneous adi-
pose tissue will be acquired using a 14 G needle to
determine basal expression of key genes related to appe-
tite and physical activity regulation (e.g. adiponectin and
leptin) and energy expenditure (e.g. UCPs).
This second phase of data collection will involve each
participant being randomly assigned either to an
extended daily fasting group (only plain water permitted
until 1200 each day) or a breakfast consumption group
(prescribed intake of ≥3000 kJ before 1100 each day, to
include at least 1500 kJ within two hours of waking) for
a period of 6 weeks [a duration previously shown to be
sufficient for dietary modification to induce detectable
changes in energy balance and body composition; [35].
To facilitate this process, participants assigned to the
breakfast group will be provided with detailed examples
of appropriately energetic breakfasts and the energy
content of other typical breakfast foods, although the
breakfasts consumed will ultimately be self-selected by
each individual on a daily basis. Upon completion of
this 6 week dietary modification, participants will return
to the laboratory for follow-up of all anthropometric
measures and a second subcutaneous adipose tissue
biopsy to determine whether the intervention has
altered the expression of those genes measured at base-
line (described above).
In relation to the stated objectives, this design there-
fore examines whether and how any acute alterations in
energy balance can culminate in chronic changes in
energy balance (i.e. the acute effects of each treatment
may be modified as participants become accustomed
and adapt to it). To further inform such questions, dur-
ing the first and last week of the intervention partici-
pants will maintain detailed weighed records of their
habitual food and fluid intakes for subsequent analysis
of daily energy and macro-nutrient intakes using dietary
analysis software (CompEat Pro). Additional data
regarding feeding patterns will be gathered via analysis
of time of day, daily frequency and energy content of
individual eating occasions, with meals defined as inges-
tion of ≥1256 kJ at any given eating occasion and snacks
defined as ingestion of <1256 kJ more than 45 minutes
before or after a meal [77]. All participants will receive
telephone reminders to ensure appropriate compliance
to the dietary record process, as has been advocated and
applied to good effect by others [24]. The food diaries
provided to participants will also be accompanied by the
same validated labelled magnitude scale [76] that parti-
cipants will have used during the first phase of testing
to provide a rating of ‘pleasantness’ following the first
and last mouthful of their lunchtime meal, thus inform-
ing research questions regarding psychological reward
and food hedonics. Concurrent to these two periods of
dietary recording, participants will also be fitted with a
combined heart-rate/accelerometer (Actiheart, CamN-
tech) in order to accurately record energy expenditure/
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each 7 day assessment period (which will also be com-
plemented by daily records of participants physical in/
activities and sleep/waking times). Importantly, at the
point when this physical activity monitor is fitted, parti-
cipants will be provided the following message both
verbally and in writing to ensure that only genuinely
meaningful behavioural responses are recorded: “Your
lifestyle choices during this free-living monitoring period
are central to this study. We are interested in any nat-
ural changes in your diet and/or physical activity habits,
w h i c hy o um a yo rm a yn o tm a k ei nr e s p o n s et ot h e
intervention. This monitoring period has been carefully
scheduled to avoid any pre-planned changes in these
habits, such as a holiday or diet/exercise plan. You
should inform us immediately if unforeseen factors
external to the study may influence your lifestyle.”
After each participant’s follow-up trial under Phase II,
participants will continue adhering to their assigned
intervention for at least 2 days to allow for the 48 hour
dietary control (although up to 7 days will be permitted
in participants for whom either the menstrual cycle
need not be controlled for or when both trials can still
occur within the follicular phase) before returning to
the laboratory to repeat their breakfast trial exactly as
described in relation to Objective i. This trial will there-
fore inform whether acute metabolic and/or behavioural
effects may be modified following chronic exposure to
each treatment. A formal exit interview will also be
incorporated into this final visit during the afternoon
post-prandial period to obtain qualitative data regarding
participants’ experiences of the study and motives for
any perceived changes in behaviour.
Objective iii - In relation to this objective, relevant data
will be gathered during the second phase of testing to
explore how interactions between extended daily fasting
may relate to insulin resistance and cardiovascular disease
risk (whether related to or independent of changes in
energy balance). From a whole-body perspective, highly
relevant data will be gathered during the first and last week
of the 6 week intervention using a subcutaneous continuous
glucose monitor (iPro, Medtronic) to record 24 hour glu-
cose profiles for each participant (thus revealing whether
either treatment alters either the average daily glucose con-
centration or the magnitude of hyperglycaemic excursions
following meals). This real-world indication of glycaemic
control will be complimented not only by simple compari-
son of changes in fasted glucose/insulin concentrations
changes over the 6 weeks but also by way of an oral glucose
tolerance test (OGTT) that will be conducted at baseline
and follow-up in Phase II, immediately following each adi-
pose tissue sample. At a more reductionist level, the adipose
tissue samples will be subjected to further analysis to deter-
mine the sensitivity of this particular tissue to insulin.
Specifically, on the day that these samples are collected, adi-
pocytes will be isolated by collagenase digestion before
determination of [U-
14C]-D-glucose uptake at basal, sub-
maximal (50 pmol￿l
-1) and maximal (20 nmol￿l
-1) insulin
concentrations. This glucose uptake assay has been shown
to accurately reflect 3-O-methylglucose transport under the
conditions described [78,79] and the resultant data will be
expressed both as pmol￿min
-1 relative both to lipid mass
[80] and, following analysis of cell size, to cell surface area.
This will be in addition to subsequent analyses for the total
protein content of GLUT4 and Akt in this tissue and the
expression of key genes implicated in lipolysis (e.g. HSL and
ATGL), lipogenesis (e.g. PPARg,P G C 1 a ,S R E B P 1 c )a n d
more generally in glucose uptake and oxidation (e.g.
GLUT4, PDK4, AMPKa- 1 / 2 ,r e s i s t i n ,R B P 4 ,l e p t i na n da d i -
ponectin) and/or insulin signalling (e.g. IRS1/2, PI3K, Akt
and TBC1 domain family member 4), thus informing
whether there is any adaptive response to the intervention
at the level of adipose tissue gene expression and protein
content.
Finally, in relation to cardiovascular disease risk, mea-
surements of blood lipid profiles, cytokine responses,
CRP and blood pressure (DINAMAP Pro 100-400 V2,
UK) will be contrasted between participants’ baseline
and final follow-up trials, as will the expression of other
relevant genes in adipose tissue samples (e.g. interleu-
kin-6 and TNF-a). All hormones/cytokines to be mea-
sured in the proposed work will be quantified via
ELISA, with whole blood glucose determined using a
YSI analyser, plasma glucose, NEFA, cholesterol and




Despite clear support for a positive relationship between
extended daily fasting, energy balance and a range of
inter-related negative health consequences, there
remains a distinct lack of evidence regarding any direct
causal relationships or mechanisms of action. The novel
data generated by this study will be critical both to the
progression of scientific understanding and to the appli-
cation of these findings within a public health setting. In
particular, very simple and easily adopted public health
messages could be communicated based on the findings
of this study, not only in terms of whether breakfast
consumption/omission represents an effective strategy
for weight loss or improved health in different popula-
tions but also the mechanisms identified can be facili-
tated to maximise such benefits.
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